催化劑製藥公司
US ˙ NasdaqCM ˙ US14888U1016

簡介

本頁面提供了有關 Patrick J Mcenany 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Patrick J Mcenany已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:CPRX / Catalyst Pharmaceuticals, Inc. Director 4,171,559
US:KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Director 122,750
如何解讀這些圖表

以下圖表顯示了在Patrick J Mcenany進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

CPRX / Catalyst Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 CPRX / Catalyst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2020-09-30 CPRX MCENANY PATRICK J 15,000 2.9700 15,000 2.9700 44,550 268 6.05 46,200 103.70
2019-10-03 CPRX MCENANY PATRICK J 10,000 4.8900 10,000 4.8900 48,900
2019-06-11 CPRX MCENANY PATRICK J 25,000 3.2300 25,000 3.2300 80,750
2018-12-19 CPRX MCENANY PATRICK J 20,000 2.2400 20,000 2.2400 44,800
2018-04-03 CPRX MCENANY PATRICK J 20,000 2.2900 20,000 2.2900 45,800
2017-09-05 CPRX MCENANY PATRICK J 20,000 2.5780 20,000 2.5780 51,560
2016-06-14 CPRX MCENANY PATRICK J 105,300 0.6508 105,300 0.6508 68,529
2016-04-26 CPRX MCENANY PATRICK J 50,000 0.6486 50,000 0.6486 32,430
2015-12-28 CPRX MCENANY PATRICK J 25,000 2.3890 25,000 2.3890 59,725
2015-10-01 CPRX MCENANY PATRICK J 10,000 2.8100 10,000 2.8100 28,100
2015-04-27 CPRX MCENANY PATRICK J 5,000 3.7900 5,000 3.7900 18,950
2015-01-08 CPRX MCENANY PATRICK J 50,000 2.7950 50,000 2.7950 139,750
2014-05-21 CPRX MCENANY PATRICK J 25,000 1.8890 25,000 1.8890 47,225
2014-02-07 CPRX MCENANY PATRICK J 25,000 1.8200 25,000 1.8200 45,500
2013-10-21 CPRX MCENANY PATRICK J 50,000 1.5946 50,000 1.5946 79,730
2013-02-19 CPRX MCENANY PATRICK J 50,000 0.4600 50,000 0.4600 23,000
2012-12-17 CPRX MCENANY PATRICK J 100,000 0.4450 100,000 0.4450 44,500
2012-11-15 CPRX MCENANY PATRICK J 100,000 0.4201 100,000 0.4201 42,010
2012-07-03 CPRX MCENANY PATRICK J 700 0.5350 700 0.5350 374
2012-07-02 CPRX MCENANY PATRICK J 30,500 0.5383 30,500 0.5383 16,418
2012-05-30 CPRX MCENANY PATRICK J 10,000 0.5790 10,000 0.5790 5,790
2012-05-24 CPRX MCENANY PATRICK J 31,250 0.8000 31,250 0.8000 25,000
2012-02-14 CPRX MCENANY PATRICK J 1,600 1.1000 1,600 1.1000 1,760
2012-02-14 CPRX MCENANY PATRICK J 23,400 1.1500 23,400 1.1500 26,910

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
CPRX / Catalyst Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 CPRX / Catalyst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2025-06-09 CPRX MCENANY PATRICK J 171,748 26.1100 171,748 26.1100 4,484,340 108 19.1300 -1,198,801 -26.73
2025-06-06 CPRX MCENANY PATRICK J 28,252 25.9450 28,252 25.9450 732,998
2024-11-20 CPRX MCENANY PATRICK J 72,500 21.2900 72,500 21.2900 1,543,525
2024-11-19 CPRX MCENANY PATRICK J 98,345 21.1880 98,345 21.1880 2,083,734
2024-11-14 CPRX MCENANY PATRICK J 44,655 21.7520 44,655 21.7520 971,336
2024-11-13 CPRX MCENANY PATRICK J 92,500 22.9780 92,500 22.9780 2,125,465
2024-11-12 CPRX MCENANY PATRICK J 70,000 23.4210 70,000 23.4210 1,639,470
2024-11-12 CPRX MCENANY PATRICK J 192,000 23.2010 192,000 23.2010 4,454,592
2024-11-11 CPRX MCENANY PATRICK J 230,000 23.5480 230,000 23.5480 5,416,040
2023-05-15 CPRX MCENANY PATRICK J 26,151 13.2300 26,151 13.2300 345,978
2022-11-21 CPRX MCENANY PATRICK J 150,000 15.3320 150,000 15.3320 2,299,800
2022-11-18 CPRX MCENANY PATRICK J 350,000 15.6220 350,000 15.6220 5,467,700
2022-09-14 CPRX MCENANY PATRICK J 946,846 15.4140 946,846 15.4140 14,594,684
2022-09-13 CPRX MCENANY PATRICK J 80,765 15.3290 80,765 15.3290 1,238,047
2022-08-19 CPRX MCENANY PATRICK J 125,000 14.0994 125,000 14.0994 1,762,425
2022-08-18 CPRX MCENANY PATRICK J 25,000 13.9340 25,000 13.9340 348,350
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9300 50,000 13.9300 696,500
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9590 50,000 13.9590 697,950
2022-08-18 CPRX MCENANY PATRICK J 50,000 13.9510 50,000 13.9510 697,550
2021-08-23 CPRX MCENANY PATRICK J 82,617 5.6250 82,617 5.6250 464,721
2021-08-20 CPRX MCENANY PATRICK J 54,161 5.5180 54,161 5.5180 298,860
2021-08-13 CPRX MCENANY PATRICK J 31,186 6.1740 31,186 6.1740 192,542
2021-08-13 CPRX MCENANY PATRICK J 31,529 6.0745 31,529 6.0745 191,523

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades
KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF內部人士買入 - 短期收益分析

在這一部分，我們分析了在 CPRX / Catalyst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 CPRX / Catalyst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades
歷史內部人交易

該表格顯示了由 Patrick J Mcenany 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2025-12-30 2025-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -6,786 4,171,559 -0.16
2025-12-30 2025-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 26,334 4,178,345 0.63
2025-12-10 2025-12-08 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 3,534 4,152,011 0.09
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		G - Gift -45,000 4,148,477 -1.07
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		G - Gift -45,000 4,148,477 -1.07
2025-12-03 2025-12-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		G - Gift -45,000 4,193,477 -1.06
2025-11-24 2025-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 1,775 4,283,477 0.04
2025-06-10 2025-06-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		S - Sale -171,748 4,281,702 -3.86 26.11 -4,484,340 111,795,239
2025-06-10 2025-06-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		S - Sale -28,252 4,453,450 -0.63 25.94 -732,998 115,544,760
2024-12-11 2024-12-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 3,533 4,481,702 0.08
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -72,500 4,478,169 -1.59 21.29 -1,543,525 95,340,218
2024-11-21 2024-11-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 72,500 4,550,669 1.62 3.54 256,650 16,109,368
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -98,345 4,478,169 -2.15 21.19 -2,083,734 94,883,445
2024-11-21 2024-11-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 98,345 4,576,514 2.20 3.54 348,141 16,200,860
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -44,655 4,478,169 -0.99 21.75 -971,336 97,409,132
2024-11-15 2024-11-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 44,655 4,522,824 1.00 3.54 158,079 16,010,797
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -92,500 4,478,169 -2.02 22.98 -2,125,465 102,899,367
2024-11-15 2024-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 92,500 4,570,669 2.07 3.54 327,450 16,180,168
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -192,000 4,478,169 -4.11 23.20 -4,454,592 103,897,999
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 192,000 4,670,169 4.29 3.54 679,680 16,532,398
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -70,000 4,478,169 -1.54 23.42 -1,639,470 104,883,196
2024-11-13 2024-11-12 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 70,000 4,548,169 1.56 4.01 280,700 18,238,158
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -230,000 4,478,169 -4.89 23.55 -5,416,040 105,451,924
2024-11-13 2024-11-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 230,000 4,708,169 5.14 4.01 922,300 18,879,758
2024-08-26 2024-08-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		G - Gift -5,100 4,478,169 -0.11
2024-08-19 2024-08-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		G - Gift -45,000 4,483,269 -0.99
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 116,667 4,528,256 2.64
2024-01-31 2024-01-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 26,333 4,411,589 0.60
2024-01-03 2024-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 250,000 4,385,256 6.05 1.13 282,500 4,955,339
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -10,362 4,135,256 -0.25
2023-12-29 2023-12-27 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 26,333 4,145,618 0.64
2023-05-17 2023-05-16 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 173,849 4,119,285 4.41 0.79 137,341 3,254,235
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -26,151 3,945,436 -0.66 13.23 -345,978 52,198,118
2023-05-17 2023-05-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 26,151 3,971,587 0.66 0.79 20,659 3,137,554
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -14,204 3,945,436 -0.36
2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 58,333 3,959,640 1.50
2022-12-30 2022-12-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		G - Gift -10,000 3,901,307 -0.26
2022-12-30 2022-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		G - Gift -10,000 3,911,307 -0.26
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -12,133 3,921,307 -0.31
2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 30,834 3,933,440 0.79
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -150,000 3,902,606 -3.70 15.33 -2,299,800 59,834,755
2022-11-22 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 150,000 4,052,606 3.84 2.24 336,000 9,077,837
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -350,000 3,902,606 -8.23 15.62 -5,467,700 60,966,511
2022-11-22 2022-11-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 350,000 4,252,606 8.97 2.24 784,000 9,525,837
2022-09-15 2022-09-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -946,846 3,902,606 -19.52 15.41 -14,594,684 60,154,769
2022-09-15 2022-09-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -80,765 4,849,452 -1.64 15.33 -1,238,047 74,337,250
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -125,000 4,930,217 -2.47 14.10 -1,762,425 69,513,102
2022-08-19 2022-08-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 125,000 5,055,217 2.54 2.53 316,250 12,789,699
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -50,000 4,930,217 -1.00 13.95 -697,550 68,781,457
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock,. par value $0.001 per share 		M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -50,000 4,930,217 -1.00 13.96 -697,950 68,820,899
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 50,000 4,980,217 1.01 2.53 126,500 12,599,949
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -50,000 4,930,217 -1.00 13.93 -696,500 68,677,923
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -25,000 4,930,217 -0.50 13.93 -348,350 68,697,644
2022-08-19 2022-08-18 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 25,000 4,955,217 0.51 2.53 63,250 12,536,699
2022-02-16 2022-02-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 175,000 3,665,834 5.01
2021-12-30 2021-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 270,000 3,490,834 8.38
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -30,833 3,220,834 -0.95
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -12,132 4,930,227 -0.25
2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 30,833 4,942,359 0.63
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		M - Exercise -120,000 3,251,667 -3.56
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -82,617 4,911,526 -1.65 5.62 -464,721 27,627,334
2021-08-24 2021-08-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 120,000 4,994,143 2.46 3.12 374,400 15,581,726
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		M - Exercise -80,000 3,371,667 -2.32
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -54,161 4,874,143 -1.10 5.52 -298,860 26,895,521
2021-08-24 2021-08-20 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 80,000 4,928,304 1.65 3.12 249,600 15,376,308
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		M - Exercise -100,000 3,451,667 -2.82
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -31,529 4,848,304 -0.65 6.07 -191,523 29,451,023
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		S - Sale -31,186 4,879,833 -0.64 6.17 -192,542 30,128,089
2021-08-17 2021-08-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 100,000 4,911,019 2.08 3.12 312,000 15,322,379
2021-01-04 2020-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 400,000 3,551,667 12.69
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -30,833 3,151,667 -0.97
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		F - Taxes -7,507 4,811,019 -0.16
2020-12-28 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share 		M - Exercise 30,833 4,818,526 0.64
2020-09-30 2020-09-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 15,000 4,787,693 0.31 2.97 44,550 14,219,448
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 92,500 3,182,500 2.99
2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 740,000 3,090,000 31.49
2019-10-03 2019-10-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 10,000 4,772,693 0.21 4.89 48,900 23,338,469
2019-06-11 2019-06-11 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 25,000 4,762,693 0.53 3.23 80,750 15,383,498
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,667 2,350,000 7.63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,667 2,350,000 7.63
2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,666 2,016,666 9.01
2018-12-19 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 20,000 4,737,693 0.42 2.24 44,800 10,612,432
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,667 1,850,000 9.90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,667 1,850,000 9.90
2018-05-31 2018-05-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 166,666 1,516,666 12.35
2018-04-03 2018-04-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 20,000 4,717,693 0.43 2.29 45,800 10,803,517
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 1,350,000 8.00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 1,350,000 8.00
2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 1,250,000 8.70
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -26,667 0 -100.00
2017-11-14 2017-11-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 26,667 4,697,693 0.57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		M - Exercise -200,000 500,000 -28.57
2017-11-07 2017-11-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 200,000 4,671,026 4.47 0.47 94,000 2,195,382
2017-09-05 2017-09-05 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 20,000 4,471,026 0.45 2.58 51,560 11,526,305
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Warrants to Purchase Common Stock 		X - Other -31,250 0 -100.00 0.80 -25,000
2017-05-22 2017-05-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 31,250 4,451,026 0.71 1.04 32,500 4,629,067
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 83,334 1,250,000 7.14
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 83,333 1,166,666 7.69
2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 83,333 1,166,666 7.69
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -26,667 26,667 -50.00
2016-11-18 2016-11-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 26,667 4,419,776 0.61
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 1,100,000 10.00
2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 1,100,000 10.00
2016-06-14 2016-06-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 105,300 4,393,109 2.46 0.65 68,529 2,859,035
2016-04-26 2016-04-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 50,000 4,287,809 1.18 0.65 32,430 2,781,073
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 900,000 12.50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 900,000 12.50
2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		A - Award 100,000 800,000 14.29
2015-12-28 2015-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 25,000 4,237,809 0.59 2.39 59,725 10,124,126
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -26,666 53,334 -33.33
2015-12-07 2015-12-07 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 26,666 4,212,809 0.64
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock 		M - Exercise -75,000 600,000 -11.11
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		F - Taxes -26,119 4,186,143 -0.62
2015-10-30 2015-10-29 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		M - Exercise 75,000 4,212,262 1.81 1.09 81,750 4,591,366
2015-10-01 2015-10-01 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share 		P - Purchase 10,000 4,137,262 0.24 2.81 28,100 11,625,706
2015-04-27 2015-04-27 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share 		P - Purchase 5,000 4,127,262 0.12 3.79 18,950 15,642,323
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		M - Exercise -364,804 786,250 -31.69
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share 		F - Taxes -67,539 4,122,262 -1.61
2015-02-27 2015-02-25 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share 		M - Exercise 364,804 4,189,801 9.54 0.68 249,891 2,870,014
2015-01-08 2015-01-08 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share 		P - Purchase 50,000 3,970,918 1.28 2.80 139,750 11,098,716
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units 		A - Award 26,667 1,151,054 2.37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units 		A - Award 26,667 1,151,054 2.37
2014-11-17 2014-11-13 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Restricted Stock Units 		A - Award 26,666 1,097,720 2.49
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 100,000 1,221,054 8.92
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 100,000 1,121,054 9.79
2014-11-04 2014-08-28 4/A CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 100,000 1,021,054 10.86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		M - Exercise -150,000 1,231,054 -10.86
2014-10-03 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share 		M - Exercise 150,000 3,920,918 3.98 0.90 135,000 3,528,826
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 153,334 1,381,054 12.49
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 153,333 1,227,720 14.27
2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 153,333 1,227,720 14.27
2014-07-02 2014-07-01 4 KOOL CESCA THERAPEUTICS INC.
Option 		A - Award 25,000 122,750 25.58
2014-05-21 2014-05-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 25,000 3,656,247 0.69 1.89 47,225 6,906,651
2014-02-07 2014-02-07 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 25,000 3,631,247 0.69 1.82 45,500 6,608,870
2013-10-21 2013-10-21 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 50,000 3,606,247 1.41 1.59 79,730 5,750,521
2013-07-02 2013-07-01 4 KOOL THERMOGENESIS CORP
Option 		A - Award 15,000 109,000 15.96
2013-02-20 2013-02-19 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 50,000 3,556,247 1.43 0.46 23,000 1,635,874
2012-12-18 2012-12-17 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 100,000 3,449,997 2.99 0.44 44,500 1,535,249
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 66,667 936,054 7.67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 66,667 936,054 7.67
2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock 		A - Award 66,666 802,720 9.06
2012-11-15 2012-11-15 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 100,000 3,349,997 3.08 0.42 42,010 1,407,334
2012-07-05 2012-07-02 4 KOOL THERMOGENESIS CORP
Option 		A - Award 15,000 100,500 17.54
2012-07-03 2012-07-03 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 700 3,249,997 0.02 0.54 374 1,738,748
2012-07-03 2012-07-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 30,500 3,249,297 0.95 0.54 16,418 1,749,097
2012-05-31 2012-05-30 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 10,000 3,218,797 0.31 0.58 5,790 1,863,683
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Warrants to Purchase Common Stock 		P - Purchase 31,250 1,009,191 3.20
2012-05-29 2012-05-24 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 31,250 3,208,797 0.98 0.80 25,000 2,567,038
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 23,400 3,202,547 0.74 1.15 26,910 3,682,929
2012-02-14 2012-02-14 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share 		P - Purchase 1,600 3,179,147 0.05 1.10 1,760 3,497,062
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）